2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide

C31H31ClN6O5 — CID 90365231

IUPAC2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC(=O)NCCc1ccc(CO)c(O)c1)c1nnc(C)n1-2
InChIInChI=1S/C31H31ClN6O5/c1-18-36-37-31-25(15-28(41)34-16-29(42)33-12-11-19-3-4-21(17-39)27(40)13-19)35-30(20-5-7-22(32)8-6-20)24-14-23(43-2)9-10-26(24)38(18)31/h3-10,13-14,25,39-40H,11-12,15-17H2,1-2H3,(H,33,42)(H,34,41)/t25-/m0/s1
InChIKeyTZTXGTJRJOCSSI-VWLOTQADSA-N
MW603.08 g/mol
LogP3.19
Rot. Bonds10

About 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide

2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide (PubChem CID 90365231) has the molecular formula C31H31ClN6O5 and a molecular weight of 603.08 g/mol. Its IUPAC name is 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide.

Molecular Properties

Compound Name2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide
PubChem CID90365231
Molecular FormulaC31H31ClN6O5
Molecular Weight603.08 g/mol
Exact Mass602.20
IUPAC Name2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide
SMILESCOc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC(=O)NCCc1ccc(CO)c(O)c1)c1nnc(C)n1-2
InChIInChI=1S/C31H31ClN6O5/c1-18-36-37-31-25(15-28(41)34-16-29(42)33-12-11-19-3-4-21(17-39)27(40)13-19)35-30(20-5-7-22(32)8-6-20)24-14-23(43-2)9-10-26(24)38(18)31/h3-10,13-14,25,39-40H,11-12,15-17H2,1-2H3,(H,33,42)(H,34,41)/t25-/m0/s1
InChIKeyTZTXGTJRJOCSSI-VWLOTQADSA-N
XLogP3.19
TPSA150.96 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds10
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500603.08
LogP ≤ 53.19
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Analyze 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide?
The IUPAC name of 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide (CID 90365231) is 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide.
What is the SMILES notation for 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide?
The canonical SMILES for 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide is COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC(=O)NCCc1ccc(CO)c(O)c1)c1nnc(C)n1-2.
What is the InChIKey of 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide?
The InChIKey is TZTXGTJRJOCSSI-VWLOTQADSA-N. The full InChI is InChI=1S/C31H31ClN6O5/c1-18-36-37-31-25(15-28(41)34-16-29(42)33-12-11-19-3-4-21(17-39)27(40)13-19)35-30(20-5-7-22(32)8-6-20)24-14-23(43-2)9-10-26(24)38(18)31/h3-10,13-14,25,39-40H,11-12,15-17H2,1-2H3,(H,33,42)(H,34,41)/t25-/m0/s1.
What are the key properties of 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide?
2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide has a molecular weight of 603.08 g/mol, XLogP of 3.19, 10 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-[2-[3-hydroxy-4-(hydroxymethyl)phenyl]ethylamino]-2-oxoethyl]acetamide is sourced from PubChem (CID 90365231), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).